Associate Professor intrigued by skin immunology, T cell lymphoma, S. aureus-T cell interactions and single-cell analyses at University of Copenhagen @ucph.bsky.social @sic-ucph.bsky.socialhttps://bsky.app/profile/terkild.bsky.socialhttps://bsky.app/profile/terkild.bsky.social/post/3mjomrzkm3s2wNew from our group: in CTCL, S. aureus is not just a bystander. Staphylococcal enterotoxins activate malignant + non-malignant T cells, amplifying cytokines that damage the epidermal barrier. This links colonization directly to pathology. doi.org/10.1111/all.70292 @allergy-eaaci.bsky.social 1/8 [contains quote post or other embedded content]17 Apr 2026 09:36 +0000at://did:plc:sm5xbfp2mmgrd2mjrloyrtcv/app.bsky.feed.post/3mjomrzkm3s2whttps://bsky.app/profile/terkild.bsky.social/post/3mjokvse7x22nHappy to share that I’ve been promoted to Associate Professor @sic-ucph.bsky.social @ucph.bsky.social . Very grateful to the mentors, group members, colleagues, students, collaborators, and family who have supported me along the way. Thank you. Looking forward to the next chapter!17 Apr 2026 09:03 +0000at://did:plc:sm5xbfp2mmgrd2mjrloyrtcv/app.bsky.feed.post/3mjokvse7x22nhttps://bsky.app/profile/terkild.bsky.social/post/3m4xeco4qw22kGlad to see our article on how cancer drugs and bacterial (S. aureus) infections can affect co-existing malignant subclones very differently in cutaneous T-cell lymphoma. Thank you Cancer Discovery (@aacrjournals.bsky.social) for the beautiful title-page graphics! [contains quote post or other embedded content]06 Nov 2025 10:31 +0000at://did:plc:sm5xbfp2mmgrd2mjrloyrtcv/app.bsky.feed.post/3m4xeco4qw22khttps://bsky.app/profile/terkild.bsky.social/post/3lrxgaranws2m❗How can a cancer exploit its environment and still resist treatment? ✅The answer: co-existing malignant subclones. Let me walk you through our latest study investigating how divergent evolution drives adaptability, aggressiveness, and drug resistance of T cell cancer. 1/🧵 https://doi.org/10.1158/2159-8290.CD-24-185619 Jun 2025 11:29 +0000at://did:plc:sm5xbfp2mmgrd2mjrloyrtcv/app.bsky.feed.post/3lrxgaranws2mhttps://bsky.app/profile/terkild.bsky.social/post/3lrxgaranws2m❗How can a cancer exploit its environment and still resist treatment? ✅The answer: co-existing malignant subclones. Let me walk you through our latest study investigating how divergent evolution drives adaptability, aggressiveness, and drug resistance of T cell cancer. 1/🧵 https://doi.org/10.1158/2159-8290.CD-24-185619 Jun 2025 11:29 +0000at://did:plc:sm5xbfp2mmgrd2mjrloyrtcv/app.bsky.feed.post/3lrxgaranws2mhttps://bsky.app/profile/terkild.bsky.social/post/3lb7vaers5s2sCan bacterial infections make cancer cells resistant to treatment? In Sézary Syndrome (SS), it turns out they can! Want to know more? I will summarize some highlights from our study below. https://doi.org/10.1182/blood.202302167118 Nov 2024 12:10 +0000at://did:plc:sm5xbfp2mmgrd2mjrloyrtcv/app.bsky.feed.post/3lb7vaers5s2shttps://bsky.app/profile/terkild.bsky.social/post/3lb2gqtztzc2hAny starter packs around for researchers in single-cell method development (not computational), dermatology, inflammatory skin disease, atopic dermatitis or cutaneous T cell lymphoma?16 Nov 2024 08:07 +0000at://did:plc:sm5xbfp2mmgrd2mjrloyrtcv/app.bsky.feed.post/3lb2gqtztzc2h